Paraneoplastic ophthalmoplegia and subacute motor axonal neuropathy associated with anti-GQ1b antibodies in a patient with malignant melanoma

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 4, 2003, Pages 507-509

  Kloos, L ^a,b   Sillevis Smitt, Peter ^a   Ang, C W ^a   Kruit, W ^a   Stoter, G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEYENBURG HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD3; GANGLIOSIDE GM2; GANGLIOSIDE GQ 1B ANTIBODY; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN M; IMMUNOLOGICAL ADJUVANT; MELANOMA ANTIGEN 3; STEROID; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CASE REPORT; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; MELANOMA; METASTASIS; MOTOR NEUROPATHY; OPHTHALMOPLEGIA; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; SYMPTOMATOLOGY;

EID: 0037379849     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.4.507     Document Type: Article

References (12)

1. Ang CW, Endtz HP, Jacobs BC, et al. Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits [in process citation]. J Neuroimmunol 2000;104:133-8.
2. Jacobs BC, Rothbarth PH, van der Meche FG, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 1998;51:1110-15.
3. Weiss MD, Luciano CA, Semino-Mora C, et al. Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma. Neurology 1998;51;1738-41.
4. Ang CW, De Klerk MA, Endtz HP, et al. Guillain-Barré syndrome and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b antibodies in rabbits. Infect Immun 2001;69:2462-9.
5. Sillevis Smitt PAE, Posner JP. Paraneoplastic peripheral neuropathy. In: Hartung H-P, ed. Peripheral neuropathies, part I. London: Baillière Tindall, 1995:443-69.
6. Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry 2001;70:50-5.
7. Jacobs BC, Meulstee J, van Doom PA, et al. Electrodiagnostic findings related to anti-GM1 and anti-GQ1b antibodies in Guillain-Barré syndrome. Muscle Nerve 1997;20:446-52.
8. O'Hanlon GM, Plomp JJ, Chakrabarti M, et al. Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain 2001;124:893-906.
9. Ortiz N, Rosa R, Gallardo E, et al. IgM monoclonal antibody against terminal moiety of GM2, GaINAc-GD1a and GaINAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release. J Neuroimmunol 2001;119:114-23.
10. Anthoney DA, Bone I, Evans TR. Inflammatory demyelinating polyneuropathy: a complication of immunotherapy in malignant melanoma. Ann Oncol 2000;11:1197-200.
11. Fuller GN, Spies JM, Pollard JD, et al. Demyelinating neuropathies triggered by melanoma immunotherapy. Neurology 1994;44:2404-5.
12. van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643-7.